Article contents
Controlled Clinical Trial of Isocarboxazid (“Marplan”) in Hospital Psychiatry
Published online by Cambridge University Press: 08 February 2018
Extract
A number of synthetic drugs have recently been introduced as specific antidepressants in psychiatry. Isocarboxazid (Marplan) is an analogue of iproniazid (Marsilid). Both belong to the monoamine oxidase inhibitor group of antidepressants. Isocarboxazid is said to be less toxic but of equal potency for a lesser dose than iproniazid. A controlled clinical trial of isocarboxazid was therefore undertaken to assess this drug in the treatment of depression. The results of this trial are reported in this paper together with the results of an uncontrolled trial in a further group of patients (group M) who received isocarboxazid only.
- Type
- Original Articles
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1961
References
- 2
- Cited by
eLetters
No eLetters have been published for this article.